GoDubai Yellow Pages
Apr 20, 2014
  GoDubai Daily News
 Home
 UAE
 Middle East
 Asia
 World
 Business
 Sports
 Entertainment


  Go Dubai Services
 Daily Horoscope
 Tip of the day
 Recipe of the day
 Joke of the day
 Weather
 Events (UAE)
 Press releases
 Prayer timings
 Opinion poll

Want to know the cheapest airfare to your dream destination?

Ask Our Travel Experts

Other Experts

  • Medical Doctors
  • Alternative Therapists
  • Finance Consultant
  • Real Estate Agents
  • Computer Experts
  • Beauty Therapists
  • Auto Expert
  • Seeking Experts
  •   Features
    UAE’s first gene testing lab soon in Abu Dhabi

    A MoU to this effect has been signed by BGI Health and the Star Metropolis Clinical Laboratories, a part of the Arabian Healthcare Group.

    The genetic testing for breast cancer made famous by Oscar winning Hollywood actress Angelina Jolie would now be locally available for UAE residents, thanks to the first genome testing lab set to open in Abu Dhabi.

    Angelina Jolie had rocked the Internet and the medical community earlier this year with a disclosure through New York Times that that she had tested positive for a faulty BRCA1 gene carrying risk of cancer and decided to undergo a preventive surgery to reduce the risk. The procedure reportedly reduced her personal risks of breast cancer from 87 percent to less than 5 percent.

    If anybody in the UAE and region had to check for BRCA gene mutations carrying the risk of cancer, samples had to be collected and sent abroad, which involved delays of weeks if not months. With the UAE’s first genome testing lab set to open in Abu Dhabi, the tests can now be done locally.

    This has been made possible by a partnership entered into between one of the leading genomic organizations in the world and a local chain of clinical laboratories. A memorandum of understanding to this effect has been signed by BGI Health and the Star Metropolis Clinical Laboratories, a part of the Arabian Healthcare Group.

    The genome testing clinical lab offering the most sophisticated tools will make it possible to develop personalised healthcare and treatments for patients as dictated by the uniqueness of their individual genes.

    BGI Health is focussed on clinical application of genetic testing technology in order to decrease birth defects and various human diseases. Under the agreement, Star Metropolis, as BGI’s partner in the UAE, will share the genetic resources of population, create joint research projects and promote sequencing-based clinical applications together with BGI. The agreement covers the UAE and other GCC countries, the Middle East and Africa regions.

    BGI Health provides genetic testing of chromosome diseases, monogenic disorder, hereditary hearing loss, thalassemia, neonatal hereditary metabolic disease, leukaemia, cervical cancer and hepatitis by using the screening and diagnosis technology system throughout the human life cycle. While the technology will be available across Star Metropolis chain of existing clinical laboratories, a new genome testing laboratory is proposed to be established in Abu Dhabi.

    ‘’With the goal towards excellence, high efficiency and accuracy, BGI has a large number of accomplishments, including sequencing 1 percent of the human genome for the international Human Genome Project, contributing 10 pe rcent of International Human HapMap Project, carrying out research to combat SARS and the E.coli outbreak in Germany and most recently sequencing the human gut metagenome project,’’ said Wang Jun, CEO of BGI.

    ‘Our partnership with BGI means that the people of the region and beyond will have access to a technology that so far remained in the realm of scientific fiction. Genome research breakthroughs have now made personalized medicine a reality and we are pleased to be able to bring such technology to the people of this region in partnership with a world leader,’ said Raza Siddiqui, CEO of Arabian Healthcare Group, who signed the MoU on behalf the UAE group.

    BGI Health applies human genome research achievements to human health with the aim of establishing what it describes as the 4P healthcare system: Prediction, Prevention, Participatory and Personalized healthcare. BGI Health is focussed on clinical application of genetic testing technology in order to decrease birth defects and various human diseases.

    The technology is expected to be particularly effective in the diagnosis, prevention and treatment of various kinds of cancer diseases.

    Genetic testing for hereditary colorectal cancer detects mutations in 14 disease-related genes, which enables early prediction of the disease risk and effective follow-up interventions.

    For instance, targeted cancer therapy attacks cancer cells, with little or no side-effect, by interfering with specific molecules required for carcinogenesis and tumour growth. Each person’s unique genetic makeup affects the selection and therapeutic response of the targeted drugs, and genetic testing can facilitate the selection of the most suitable targeted therapy to achieve desired treatment outcomes.

    In treatments like the widely used chemotherapy, only 30-50% of patients respond favourably as genetic differences in the drug metabolic pathway can affect individual responses and sensitivity to chemotherapeutic drugs. But it has been found that genetic testing of relevant genetic polymorphisms can be used to prevent drug misuse, decrease toxicity and improve treatment efficacy.

    (Wam)

     
    Email this article Print this article Discuss this article
     
     
    Back to Home Main page >>

    How to be a soccer fan in the age of austerity

    GDANSK - Couch-surfing, a junk-food diet, bootleg kits, budget flights at punishing hours, and above all enough passion for the beautiful game to remind yourself why you endure this.
    Welcome to the life of a football fan in the age of austerity. <...
    The number game

    WITH THE world’s second most populated country readying to go to the hustings from April 7, demographics are going to play an important role in determining the results. This time, it is the young and first-time voters who are expected to make a difference.

     
    Citylife Ad
     
      More Top Stories in Features
    How to be a soccer fan in the age of austerity
    With Siri and new alliances, Apple takes on Google search
    How to be a soccer fan in the age of austerity
    At UN, Obama faces problems on larger stage
    Wounded children show ferocity of Misrata’s war
    Red flag falls in India
    Is WikiLeaks leaking? Norwegian paper scoops Assange
    Graft row threatens India PM legacy, exposes weakness
    Without driver or map, vans go from Italy to China
    Pakistan flood victims going into debt to rebuild
    US often weighed N Korea ‘nuke option’
    Amid games chaos, India is still a rising power
    Ayodhya: then and now


    Dubai Q1 trade hits Dh326b
    Cash buyers buoy UAE real estate market
    Etisalat offers shared data plans for business customers
    Dubai Holding unit’s profit jumps
    Emaar Properties launches ‘Samara’ villas
    Expo 2020 boosts growth, investment opportunities
    Nakheel eyes Dh8 billion new projects
    Empower acquires Palm Utilities in $500m deal
    China may overtake US as No. 1 economy
    Dubai Investments exports rocket 129% in last 5 years
    UAE equities to stay bullish
    Dubai foreign trade crosses Dh1 trillion
    Expo win inspiring Dubai Financial Market
    Dubai looks all set to enjoy heightened investor interest
    Dubai to hike spending 11%
    Dubai to lead Islamic economy
    Islamic economy summit begins today
    UAE jumps in IDI ranking
    Dubai tracks new levels of growth
    More housing units in Dubai
    UAE job market rebounds
    Safe haven status helps Dubai real estate recover
    Islamic finance industry is fastest growing sector

     
    © 2004 GoDubai.com
    All Rights Reserved.
    Terms under which this service is provided to you.
    Read our privacy guidelines.
    Contact our advertising team for advertising /promotions and
    sponsorship on GoDubai.com